Incidence, Risk Factors and Clinical Impact of Sars-Cov-2 Prolonged Viral Shedding in Patients Diagnosed with Hematologic Malignancies

被引：0

作者：

Jimenez, Moraima ^{[1
]}

Navarro Garces, Victor ^{[2
]}

Medina, Irene ^{[3
]}

Andres, Cristina ^{[4
]}

Martinez-Gallo, Monica ^{[5
]}

Medina, Daniel ^{[6
,7
]}

Anton, Andres ^{[4
]}

Albasanz-Puig, Adaia ^{[8
]}

Cabirta Touzon, Alba ^{[6
,9
]}

Perez Gonzalez, Ana ^{[10
]}

Serna, Angel ^{[11
,12
]}

Iraola-Truchuelo, Josu ^{[13
]}

Pumarola, Tomas ^{[14
]}

Hernandez, Manuel ^{[5
]}

Ruiz Camps, Isabel ^{[15
]}

Valcarcel Ferreiras, David ^{[16
,17
]}

Crespo, Marta ^{[6
,7
,9
]}

Esperalba, Juliana ^{[14
]}

Bosch, Francesc ^{[18
,19
]}

Abrisqueta Costa, Pau ^{[12
,20
]}

机构：

[1] Vall Hebron Univ Hosp, Vall Hebron Inst Oncol, Barcelona, Spain

[2] Hosp Univ Vall Hebron, Vall Hebron Inst Oncol VHIO, Oncol Data Sci ODysSey, Barcelona, Spain

[3] Vall Hebron Hosp Univ, Vall Hebron Inst Oncol VHIO, Serv Hematol, Expt Hematol, Vall Hebron Barcelona Hosp Campus,Passeig Vall He, Barcelona 08035, Spain

[4] Vall Hebron Hosp Univ, Vall Hebron Inst Recerca VHIR, Dept Microbiol, Vall Hebron Barcelona Hosp Campus,Passeig Vall He, Barcelona 08035, Spain

[5] Autonomous Univ Barcelona UA, Vall Hebron Res Inst, Vall Hebron Hosp Univ, Dept Cell Biol Physiol & Immunol, Vall Hebron Barcelona Hosp Campus, Barcelona, Spain

[6] Vall Hebron Inst Oncol VHIO, Expt Hematol, Barcelona, Spain

[7] Univ Autonoma Barcelona, Dept Med, Bellaterra, Spain

[8] Vall Hebron Univ Hosp, Infect Dis, Barcelona, Spain

[9] Univ Autonoma Barcelona, Dept Med, Bellaterra, Spain

[10] Univ Autonoma Barcelona UAB, Vall Hebron Univ Hosp, Dept Hematol, Barcelona, Spain

[11] Univ Hosp Vall Hebron, Vall Hebron Inst Oncol VHIO, Dept Hematol, Barcelona, Spain

[12] Univ Hosp Vall Hebron, Barcelona, Spain

[13] Vall Hebron Univ Hosp, Barcelona, Spain

[14] Vall Hebron Hosp Univ, Dept Microbiol, Vall Hebron 1, Barcelona, Spain

[15] Vall Hebron Hosp Univ, Dept Infect Dis, Vall H, Barcelona, Spain

[16] Univ Hosp Vall Hebron, Vall Hebron Inst Oncol VHIO, Dept Hematol, Barcelona, Spain

[17] Univ Autonoma Barcelona UAB, Vall Hebron Univ Hosp, Vall Hebron Inst Oncol VHIO, Expt Hematol Unit, Barcelona, Spain

[18] Vall Hebron Barcelona Hosp Campus, Expt Hematol, Vall Hebron Inst Oncol VHIO, Barcelona, Spain

[19] Univ Hosp Vall Hebron, Vall Hebron Inst Oncol VHIO, Dept Hematol, Barcelona, Spain

[20] Hosp Valle De Hebron, Vall Hebron Inst Oncol VHIO, Dept Hematol, Barcelona, Spain

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-191146

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 50 条

[21] Machine learning based predictive modeling and risk factors for prolonged SARS-CoV-2 shedding
Zhang, Yani
Li, Qiankun
Duan, Haijun
Tan, Liang
Cao, Ying
Chen, Junxin
JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
[22] Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies
Malard, Florent
Gaugler, Beatrice
Gozlan, Joel
Bouquet, Lucie
Fofana, Djeneba
Siblany, Lama
Eshagh, Deborah
Adotevi, Olivier
Laheurte, Caroline
Ricard, Laure
Dulery, Remy
Stocker, Nicolas
van de Wyngaert, Zoe
Genthon, Alexis
Banet, Anne
Memoli, Mara
Ikhlef, Souhila
Sestilli, Simona
Vekhof, Anne
Brissot, Eolia
Marjanovic, Zora
Chantran, Yannick
Cuervo, Nancy
Ballot, Eric
Morand-Joubert, Laurence
Mohty, Mohamad
BLOOD CANCER JOURNAL, 2021, 11 (08)
[23] Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies
Florent Malard
Béatrice Gaugler
Joel Gozlan
Lucie Bouquet
Djeneba Fofana
Lama Siblany
Deborah Eshagh
Olivier Adotevi
Caroline Laheurte
Laure Ricard
Rémy Dulery
Nicolas Stocker
Zoe van de Wyngaert
Alexis Genthon
Anne Banet
Mara Memoli
Souhila Ikhlef
Simona Sestilli
Anne Vekhof
Eolia Brissot
Zora Marjanovic
Yannick Chantran
Nancy Cuervo
Eric Ballot
Laurence Morand-Joubert
Mohamad Mohty
Blood Cancer Journal, 11
[24] Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies
Greenberger, Lee M.
Saltzman, Larry A.
Senefeld, Jonathon W.
Johnson, Patrick W.
DeGennaro, Louis J.
Nichols, Gwen L.
CANCER CELL, 2021, 39 (08) : 1031 - 1033
[25] Clinical factors associated with viral shedding time of SARS-CoV-2 Omicron variant in Japan
Akata, Kentaro
Yamasaki, Kei
Kohrogi, Rikuto
Kawakami, Yoko
Furuya, Yorikazu
Eto, Kohichiro
Honda, Masahisa
Suzuki, Katsunori
Yatera, Kazuhiro
JOURNAL OF INFECTION AND CHEMOTHERAPY, 2024, 30 (02) : 172 - 175
[26] Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination
Guven, Deniz C.
Sahin, Taha K.
Akin, Serkan
Uckun, Fatih M.
ONCOLOGIST, 2022, 27 (04): : E357 - E361
[27] Factors associated with prolonged viral shedding and impact of lopinavir/ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection
Yan, Dan
Liu, Xiao-Yan
Zhu, Ya-nan
Huang, Li
Dan, Bi-tang
Zhang, Guo-jun
Gao, Yong-hua
EUROPEAN RESPIRATORY JOURNAL, 2020, 56 (01)
[28] SARS-CoV-2 viral load and shedding kinetics
Olha Puhach
Benjamin Meyer
Isabella Eckerle
Nature Reviews Microbiology, 2023, 21 : 147 - 161
[29] SARS-CoV-2 viral load and shedding kinetics
Puhach, Olha
Meyer, Benjamin
Eckerle, Isabella
NATURE REVIEWS MICROBIOLOGY, 2023, 21 (03) : 147 - 161
[30] Therapy in Patients with Hematologic Malignancies, Seroconversion Rates, and SARS-CoV-2 Vaccination
Sriwijitalai, Won
Wiwanitkit, Viroj
ONCOLOGIST, 2022, 27 (11): : E916 - E916

← 1 2 3 4 5 →